
Fund Name | Location |
Alabama Futures Fund | Alabama, Birmingham, United States |
Anhui Kexun Venture Capital | - |
BHL Holdings | - |
C-Mer Eye Care Holdings | China, Hong Kong, Hong Kong Island |
Credit China FinTech Holdings | China, Pudong, Shandong |
E Squared Investments | Gauteng, NA - South Africa, South Africa |
Implistic Capital | Las Vegas, Nevada, United States |
Jett Capital Advisors | New York, New York, United States |
Kirin Ventures | - |
L Catterton Asia | Central, Central Region, Singapore |
Lineage Logistics | Michigan, Novi, United States |
Meisheng Cultural & Creative | China, Xinchang, Zhejiang |
MingJiang Touzi | China, Shanghai |
Mogao Venture Capital | China, Guangdong, Shenzhen |
Newfire Global Partners | Cambridge, Massachusetts, United States |
Propel(X) | California, San Francisco, United States |
Sunny Optical Technology | China, Yuyao, Zhejiang |
Tokai Tokyo Financial Holdings | Chiyoda, Japan |
TR.PE | Istanbul, Istanbul, Turkey |
University of Southampton | England, Southampton, United Kingdom |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Aspecta.ai | 19 Apr 2022 | New Haven, Connecticut, United States | |||
Regenerative Bio | $10M | 25 Feb 2022 | Cambridge, Massachusetts, United States | ||
Cardea Bio | 12 Jan 2021 | San Diego, California, United States | |||
Manus Bio Inc | 17 Nov 2020 | Cambridge, Massachusetts, United States | |||
Pointcloud | 25 Sep 2020 | San Francisco, California, United States | |||
Butlr | 01 Sep 2020 | Redwood City, California, United States | |||
Cardea Bio | 19 Aug 2020 | San Diego, California, United States | |||
Kula Bio | $5M | 13 Aug 2020 | Massachusetts, United States | ||
Lightelligence | 10 Jun 2020 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.